These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11354308)

  • 61. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells.
    Liang YW; Zheng J; Li X; Zheng W; Chen T
    Eur J Med Chem; 2014 Sep; 84():335-42. PubMed ID: 25036792
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B.
    Cunha RL; Urano ME; Chagas JR; Almeida PC; Bincoletto C; Tersariol IL; Comasseto JV
    Bioorg Med Chem Lett; 2005 Feb; 15(3):755-60. PubMed ID: 15664852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
    Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
    Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
    Lu J; Chew EH; Holmgren A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
    U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
    Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potent activity of indolequinones against human pancreatic cancer: identification of thioredoxin reductase as a potential target.
    Yan C; Shieh B; Reigan P; Zhang Z; Colucci MA; Chilloux A; Newsome JJ; Siegel D; Chan D; Moody CJ; Ross D
    Mol Pharmacol; 2009 Jul; 76(1):163-72. PubMed ID: 19364812
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 3-Nitro-2H-chromenes as a new class of inhibitors against thioredoxin reductase and proliferation of cancer cells.
    Xiao GQ; Liang BX; Chen SH; Ou TM; Bu XZ; Yan M
    Arch Pharm (Weinheim); 2012 Oct; 345(10):767-70. PubMed ID: 22836584
    [TBL] [Abstract][Full Text] [Related]  

  • 68. De novo design of thioredoxin reductase-targeted heterometallic titanocene-gold compounds of chlorambucil for mechanistic insights into renal cancer.
    Tabrizi L; Olasunkanmi LO; Fadare OA
    Chem Commun (Camb); 2019 Dec; 56(2):297-300. PubMed ID: 31808475
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
    Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
    Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer.
    Abdullah NA; Inman M; Moody CJ; Storr SJ; Martin SG
    Invest New Drugs; 2021 Oct; 39(5):1232-1241. PubMed ID: 33768386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thioredoxin reductase as a novel molecular target for cancer therapy.
    Nguyen P; Awwad RT; Smart DD; Spitz DR; Gius D
    Cancer Lett; 2006 May; 236(2):164-74. PubMed ID: 15955621
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interaction of adenanthin with glutathione and thiol enzymes: selectivity for thioredoxin reductase and inhibition of peroxiredoxin recycling.
    Soethoudt M; Peskin AV; Dickerhof N; Paton LN; Pace PE; Winterbourn CC
    Free Radic Biol Med; 2014 Dec; 77():331-9. PubMed ID: 25289458
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy.
    Wang X; Zhang J; Xu T
    Eur J Pharmacol; 2008 Jan; 579(1-3):66-73. PubMed ID: 18028906
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Properties and biological activities of thioredoxins.
    Powis G; Montfort WR
    Annu Rev Biophys Biomol Struct; 2001; 30():421-55. PubMed ID: 11441809
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
    J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A; Berggren M; Gasdaska JR; Powis G
    Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
    Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
    Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.